A personalized method for interpreting blood tests identifies more ovarian cancer cases than a generalized approach, a new study suggests. Steven Skates, associate professor of medicine at Massachusetts General Hospital, is a coauthor of the research.
Trending News
Search for Babesiosis Treatment Gets a New Map
New clues to help fight tick-borne disease
Can an AI ‘Co-Scientist’ Accelerate Cancer Research?
Nearly $7 million funds agentic AI tools to assist investigations into cancer’s most pressing…
First Large-Scale Study Shows How Doctors Use AI in Medicine
Which practitioners use artificial intelligence in the clinic, and what do they ask?